Shigella boydii
Shigella boydii is a species of Shigella, a genus of Gram-negative bacteria that is responsible for causing bacterial dysentery, a type of gastroenteritis. This species is named after the American bacteriologist, Frederick Chapman Boyd, who first isolated it.
Taxonomy
Shigella boydii is one of the four species of the Shigella genus, the others being Shigella dysenteriae, Shigella flexneri, and Shigella sonnei. The genus is part of the family Enterobacteriaceae, which also includes other significant pathogens like Escherichia coli and Salmonella.
Characteristics
Shigella boydii is a non-motile, non-spore forming, rod-shaped bacterium. It is Gram-negative, meaning it does not retain the violet stain used in the Gram stain method. Instead, it takes up the red counterstain. The bacterium is also facultative anaerobic, which means it can grow in both the presence and absence of oxygen.
Pathogenesis
Shigella boydii is one of the causative agents of bacterial dysentery, a severe form of diarrhea. The bacterium invades the cells of the intestinal lining, causing inflammation and cell death. This leads to the symptoms of dysentery, which include bloody diarrhea, abdominal cramps, and fever.
Epidemiology
Shigella boydii is less common than the other Shigella species, but it can still cause outbreaks of dysentery. It is most commonly found in developing countries with poor sanitation. The bacterium is transmitted via the fecal-oral route, often through contaminated food or water.
Treatment
Treatment for Shigella boydii infection typically involves antibiotics to kill the bacteria, along with rehydration therapy to replace lost fluids. However, antibiotic resistance is a growing concern, making it increasingly important to use these drugs judiciously.
Prevention
Prevention of Shigella boydii infection involves improving sanitation, safe food handling practices, and access to clean water. Vaccines are currently under development but are not yet widely available.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

